Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126208461 | 12620846 | 1 | I | 20110803 | 20111019 | 20160804 | 20160804 | EXP | US-ROCHE-1007379 | ROCHE | 79.00 | YR | F | Y | 60.00000 | KG | 20160804 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126208461 | 12620846 | 1 | PS | Vismodegib | VISMODEGIB | 1 | Oral | QD, TOTAL DOSE ADMINISTERED:1050 MG | Y | 203388 | CAPSULE | ||||||||
| 126208461 | 12620846 | 2 | SS | Erlotinib | ERLOTINIB | 1 | Oral | QD, TOTAL DOSE ADMINISTERED:525 MG | Y | 53728 | TABLET | ||||||||
| 126208461 | 12620846 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | TOTAL DOSE ADMINISTERED: 1000 MG. OVER 30 MIN ON DAYS 1, 8, 15, 22, 29, 36,AND 43 | Y | 0 | 1000 | MG/M**2 | /wk | ||||||
| 126208461 | 12620846 | 4 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 126208461 | 12620846 | 5 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | 0 | ||||||||||||
| 126208461 | 12620846 | 6 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126208461 | 12620846 | 1 | Adenocarcinoma pancreas |
| 126208461 | 12620846 | 2 | Adenocarcinoma pancreas |
| 126208461 | 12620846 | 3 | Adenocarcinoma pancreas |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126208461 | 12620846 | OT |
| 126208461 | 12620846 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126208461 | 12620846 | Abdominal pain | |
| 126208461 | 12620846 | Neutrophil count decreased | |
| 126208461 | 12620846 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126208461 | 12620846 | 1 | 20110728 | 20110803 | 0 | |
| 126208461 | 12620846 | 2 | 20110728 | 20110803 | 0 | |
| 126208461 | 12620846 | 3 | 20110728 | 20110728 | 0 |